EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art

Federico Diotallevi iD, Helena Gioacchini, Edoardo De Simoni, Andrea Marani, Matteo Candelora, Matteo Paolinelli iD, Elisa Molinelli, Annamaria Offidani, Oriana Simonetti

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24054910 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Federico Diotallevi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60121 Ancona, Italy. Hauptthemen laut MEDLINE: Vitiligo, Hypopigmentation. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitiligo is an acquired hypopigmentation of the skin due to a progressive selective loss of melanocytes; it has a prevalence of 1–2% and appears as rounded, well-demarcated white macules. The etiopathology of the disease has not been well defined, but multiple factors contribute to melanocyte loss: metabolic abnormalities, oxidative stress, inflammation, and autoimmunity. Therefore, a convergence theory was proposed that combines all existing theories into a comprehensive one in which several mechanisms contribute to the reduction of melanocyte viability. In addition, increasingly in-depth knowledge about the disease’s pathogenetic processes has enabled the development of increasingly targeted therapeutic strategies with high efficacy and fewer side effects. The aim of this paper is, by conducting a narrative review of the literature, to analyze the pathogenesis of vitiligo and the most recent treatments available for this condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoHypopigmentationHumansMelanocytesSkinOxidative Stress

Stichwörter der Autor:innen

Janus kinase inhibitorsafamelanotidepathogenesisprostaglandintreatmentsvitiligo

Autor:innen und Institutionen

  • Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60121 Ancona, Italy.

ORCID-Profile: Federico Diotallevi, Matteo Paolinelli

Zitieren

APA

Diotallevi, F., Gioacchini, H., De Simoni, E., Marani, A., Candelora, M., Paolinelli, M., Molinelli, E., Offidani, A., & Simonetti, O. (2023). Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054910

Vancouver

Diotallevi F, Gioacchini H, De Simoni E, Marani A, Candelora M, Paolinelli M, et al. Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054910

BibTeX
@article{Diotallevi2023,
  author = {Diotallevi, Federico and Gioacchini, Helena and De Simoni, Edoardo and Marani, Andrea and Candelora, Matteo and Paolinelli, Matteo and Molinelli, Elisa and Offidani, Annamaria and Simonetti, Oriana},
  title = {Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24054910}
}
Kostenlos starten →